Molecular Testing of Lung Cancers

Targeted therapies guided by molecular diagnostics have become a standard treatment of lung cancer. Epidermal growth factor receptor (EGFR) mutations and anaplastic lymphoma kinase (ALK) rearrangements are currently used as the best predictive biomarkers for EGFR tyrosine kinase inhibitors and ALK i...

Descripción completa

Detalles Bibliográficos
Autores principales: Shim, Hyo Sup, Choi, Yoon-La, Kim, Lucia, Chang, Sunhee, Kim, Wan-Seop, Roh, Mee Sook, Kim, Tae-Jung, Ha, Seung Yeon, Chung, Jin-Haeng, Jang, Se Jin, Lee, Geon Kook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Pathologists and the Korean Society for Cytopathology 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445209/
https://www.ncbi.nlm.nih.gov/pubmed/28427247
http://dx.doi.org/10.4132/jptm.2017.04.10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445209/
https://www.ncbi.nlm.nih.gov/pubmed/28427247
http://dx.doi.org/10.4132/jptm.2017.04.10

Ejemplares similares